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Summary: In this study, the comparative effects of half, normal and double clinical doses of artesunate; 
artesunate/sulfadoxine/pyrimethamine; artesunate/amodiaquine and their combinants (sulfadoxine/pyrimethamine 
and amodiaquine) on the semen parameters- total sperm count, motility, morphology, debris and 
premature/primordial cell count of the male guinea-pig were investigated.  The agents caused significant (p<0.05) 
decreases in total sperm count and sperm motility, with increases in abnormal sperm cells (morphology), debris and 
premature sperm cells. The effects were maximal at the subclinical doses and synergistic in the ACTs, compared to 
those of the individual partner agents.   Artesunate, amodiaquine and artesunate/amodiaquine caused 54, 28 and 84% 
decreases in total sperm count, with 13, 31 and 64% decreases in sperm motility respectively. Conversely, the above 
drugs increased baseline morphology by 70, 30 and 264% respectively. Similar synergistic responses were obtained 
with artesunate/sufadoxine/pyrimethamine. These results may be explained in terms of the oxidative effects of these 
agents, through generation of free radicals, resulting in pathological damage to testicular structure/function.  
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Introduction 
Malaria is caused by four species of 
Plasmodium- Plasmodium falciparum, Plasmodium 
vivax, Plasmodium ovale or Plasmodium malariae. 
Of these, P. falciparum accounts for majority of 
clinical cases and mortalities (Bozdech et al., 2003) 
Effective treatment of malaria had been a great 
challenge to medicine and this has impacted 
enormously on man’s health and economy (WHO, 
1998; Sachs and Malaney, 2002). Treatment failures 
in malaria have been linked majorly to the 
development of resistance of the malaria parasite to 
standard antimalarial agents (Bruce-Chwatt, 1981; 
Markwalder and Meyer, 1982; Djimdé et al., 2001). 
Consequently, different antimalarial agents and 
regimens have been developed over the period to 
cope with this challenging problem (Bruce-Chwatt, 
1981). The present choices of drugs are the 
artemisinin and its derivatives (White, 1997; Haynes, 
2001). Also, better cure rates and clearance of the 
malaria parasite from the blood are achieved with the 
artesmisin-based combination therapies (ACTs), 
which include- artesunate/ amodiaquine, 
artesunate/sulfadoxine/pyrimethamine, 
artesunate/mefloquine and artemether/ lumefantrine 
(Toure and Oduola, 2004; Nosten and White, 2007). 
Furthermore, most antimalarial agents have 
been associated with male reproductive dysfunction 
in laboratory animals (Joshi et al., 1996; Adeeko and 
Dada, 1998; Parveen et al., 2003). Studies with 
mice/albino rats had shown that chloroquine, quinine 
(Adeeko and Dada, 1998), halofantrine (Orisakwe et 
al., 2003) and artemsinins (Nwanjo et al., 2007) 
adversely affect sperm parameters. However, a 
comparative study on the effects of artemisinins, 
ACTs and combinants on these parameters to 
evaluate the therapeutic indices of ACTs had not 
been done. In an earlier study that we carried out, 
ACTs caused potentiation of the inhibitory actions of 
artemisinins and the combinant agents on serum 
testosterone. The aim of this study was therefore to 
investigate if there will be a positive correlative 
effect of the hormonal results with sperm parameters 
of the guinea-pig. 
 
Materials and Methods 
Drugs 
All the drugs used in this study were obtained 
from the University of Port Harcourt Teaching 
Hospital (UPTH), Port Harcourt. The artemisinin 
derivative used was artesunate (Arinate), 
manufactured by ERFA, Rue des Cultivateurs 25, 
1040 Brussels. The ACTs were 
artesunate/sulphadoxine/ pyrimethamine (Farenax) 
and artesunate/amodiaquine (Dart)  manufactured by 
Swiss Pharma Nigeria Ltd, Lagos, Nigeria; while the 
combinant drugs were amodiaquine (Camoquine) 
manufactured by Pfizer Afrique de I’Quest BP 3857 
– Dakar R.P. Senegal and sulfadoxine/pyrimethamine 
(Fansidar) by Swiss Pharma Nigeria Ltd, Lagos, 
Nigeria. The agents were dissolved in distilled water 
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obtained from the Department of Chemistry, Faculty 
of Sciences, University of Port Harcourt and 
administered orally. 
 
Animals: 
Outbred strains of adult male guinea-pigs (GPs) 
of average weight 450±5g were obtained from the 
animal house of the University of Port Harcourt, 
Nigeria and allowed to acclimatize for 14 days. The 
guinea-pigs were fed with alfalfa feeds daily ad 
libitum at a room temperature of 28
o
C±2 with 12-h 
light/dark cycle. Water was given ad libitum. 
 
The effects on reproductive hormones  
Protocol 
The animals were divided into six (6) groups- 
A, B, C, D, E and F of five animals each.  The 
animals in group A (the control) were orally 
administered with distilled water, while those in 
group B were orally administered with 2mg/kg body 
weight of artesunate 12-hourly for three days. 
Animals in group C were orally administered with 
10mg base/kg body weight of amodiaquine once 
daily for three days, while those in group D were 
orally given a single dose of 1.25/25 mg base/kg 
body weight of sulfadoxine/pyrimethamine. The 
animals in group E were orally dosed with 4 mg/kg 
body weight of artesunate and 10mg base/kg body 
weight of amodiaquine once a day for 3 days. Finally, 
the animals in group F received 4 mg/kg body weight 
of artesunate,
 
given once a day for 3 days and a single 
administration of 1.25/25 mg base/kg of 
sulfadoxine/pyrimethamine orally. These were all 
normal clinical doses of the agents (Barnes et al., 
2006; Nosten and White, 2007). 
These experiments with the antimalarial agents 
were carried out simultaneously with other sets of 
animals using half and double the normal clinical 
doses of the antimalarial agents. 
At the end of the series of experiments (i.e each 
treatment course), the animals were sacrificed, the 
caudal epidermis was dissected out and semen was 
carefully extracted from the epididymis and analyzed 
for motility (calculated as percentage).  The 
epididymal sperm count was performed with a 
haemocytometer and the morphology, debris and 
premature/primordial cell counts (expressed in 
percentages) were also noted. 
 
Statistical analysis 
Data were expressed as means ± standard errors 
of mean. Comparisons between control and treated 
groups of guinea-pigs were performed with one-way 
analysis of variance (ANOVA), followed by 
Duncan’s multiple comparison test. Statistical 
significance was set at P<0.05. 
Results 
In n=5, the agents were generally toxic on the 
semen parameters of the guinea-pig. Total sperm 
count was significantly decreased (P<0.05) by all the 
agents used in this study at the different doses. The 
effects were more significant at subclinical and 
double clinical doses (Figs. 1a and b). At the 
subclinical dose, amodiaquine, artesunate and 
artesunate/ amodiaquine decreased the control sperm 
count from 55.50±3.8 to 40.00±7.6, 25.33±4.7 and 
9.00±1.5 (i.e. 28, 54 and 84% decreases) respectively 
(Fig. 1a). Similarly, the values for sulfadoxine/ 
pyrimethamine and artesunate/ 
sulfadoxine/pyrimethamine were 39.00± 7.4 and 
18.67±0.33- representing 30 and 66% decreases 
(Figs. 1b). These values were very significant at 
p<0.05 ANOVA. The effects were similar at the 
normal and double clinical doses, showing that the 
combination agents (i.e. ACTs) cause potentiation 
(synergy) of the adverse effects of the individual 
agents on total sperm.  
In n=5, sperm motility was also significantly 
decreased (p<0.05) by the agents. This effect was 
dose-dependent with amodiaquine, artesunate, 
sulfadoxine/ pyrimethamine and 
artesunate/sulfadoxine/pyrimethamine, and non-
dependent with artesunate/amodiaquine. At the 
normal clinical dose, the control motility value was 
respectively decreased from 55.50±5.2 to 48.33±1.70, 
38.33±4.4 and 20.00±12.6 by artesunate, 
amodiaquine and artesunate/amodiaquine, which 
represent 13, 31 and 64% decreases (Fig. 2a). 
Similarly, the values obtained with 
sulfadoxine/pyrimethamine and 
artesunate/sulfadoxine/pyrimethamine were 
44.00±7.0 and 43.00±2.0 (representing 21 and 23% 
decreases) respectively (Fig 2b). These values show 
synergistic response by the ACTs.  
In n=5, the antimalarial agents caused increases 
in morphology, debris and primordial/premature 
sperm cells which were statistically significant 
(p<0.05) at the three different doses. The effects were 
however most pronounced at the subclinical dose, 
with the agents (artesunate, amodiaquine, 
artesunate/amodiaquine) increasing the baseline 
morphology value from 13.75±2.4 to 23.33±1.7, 
15.00±2.9 and 50.00±11.5 (representing 70, 30 and 
264% increases) respectively and (sulfadoxine 
/pyrimethamine and artesunate/sulfadoxine/ 
pyrimethamine) to 18.33±6.0, 30.00±2.9 
(representing 33 and 118% increases) respectively 
(Figs. 3a and b). These data show that the artemisinin 
combinations cause higher levels of toxicities on the 
morphology than the individual agents alone.  
Furthermore, while artesunate, 
sulfadoxine/pyrimethamine and 
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artesunate/sulfadoxine/ pyrimethamine caused dose-
dependent increases, artesunate/amodiaquine 
increased debris non-dose-dependently (Figs. 4a and 
b). Baseline debris value changed from 11.50±1.2 to 
34.33±1.9, 18.00±1.0 and 54.67±1.2 when treated 
with artesunate, amodiaquine, 
artesunate/amodiaquine, resulting in 199, 57 and 
375% increases respectively; whereas  
sulfadoxine/pyrimethamine and 
artesunate/sulfadxine/pyrimethamine increased the 
control value to 19.00±1.4 and 45.67±13.0 (57 and 
297% increases) respectively (Figs. 4a and b). In 
addition, the agents caused marked proliferation of 
premature/primordial cells at the various doses (not 
shown). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 1: The effects of antimalarial agents on the Total Sperm Count of the male GP. Data are expressed as mean ± 
 SEM, n=5; *Significantly different from control  at P< 0.05 ANOVA. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 2: The effects of antimalarial agents on the Sperm Motility of the male GP. Data are expressed as mean ± SEM, 
 n=5; *Significantly different from control  at P< 0.05 ANOVA. 
 
(a) (b) 
(a) 
(b) 
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Fig. 3: The effects of antimalarial agents on the Sperm Morphology of the male GP. Data are expressed as mean ± 
 SEM, n=5; *Significantly different from control  at P< 0.05 ANOVA. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 4: The effects of antimalarial agents on the Sperm Debris of the male GP. Data are expressed asmean ± SEM, 
 n=5; *Significantly different from control at P< 0.05 ANOVA.  
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Discussion 
In this study, the effects of different doses of 
artesunate, ACTs and their combinants on sperm 
parameters of the male guinea-pig were investigated. The 
sperm parameters investigated include- total sperm count, 
percentage motility, percentage morphology and percentage 
debris. 
The testis, which is the major male reproductive organ, 
is responsible for sperm production or spermatogenesis. 
Spermatogenesis is the process of transformation of male 
germ cells into spermatozoa and occurs mainly in the 
avascular seminiferous tubules. It is a continual process 
involving mitosis of the male germ cells that undergo 
extensive morphological changes in cell shape and 
ultimately, meiosis to produce the haploid 
spermatozoa (Clermont, 1972; De Krester and Kerr, 
1988). However, hormonal function is vital to normal 
spermatogenesis (Ganong, 2001). Spermatogenesis 
requires high intratesticular levels of testosterone, 
produced by the Leydig cells, which are scattered in a 
vascular, loose connective tissue between the 
seminiferous tubules in the interstitial compartment. 
Testosterone is particularly necessary to give growth 
and support to the Sertoli cells that contains the germ 
cells (Ganong, 2001).   
In our earlier study on testicular hormones, 
artemisinin, ACTs and their combinants caused 
inhibitions of serum LH, FSH and testosterone levels 
in the male guinea-pig. This effect was most 
pronounced on testosterone, causing potentiations in 
the effects of the partner agents, especially at the 
subclinical dose. 
In this study, the agents caused significant 
destructions of the semen parameters of the male 
guinea-pig which is consistent with precious studies 
(Orisakwe et al., 2003; Raji et al., 2005). Total sperm 
count and motility were highly reduced, while 
morphology and debris were greatly increased. 
Furthermore, the artemisinin-based combination 
agents caused synergistic results when compared 
with the individual agents in the therapy, showing 
that the ACTs may be more toxic on the testis 
compared with monotherapy with the individual 
agents in the combination. The effects were also 
more pronounced at the subclinical doses of the 
agents, which points out that the hormonal effects of 
these agents are positively correlated with their 
effects on sperm parameters. This is in agreement 
with the reports of Elkington and Blackshaw, (1974) 
and Ganong, (2001)   
The effects observed in this study may be due to 
damages to the Leydig cells and seminiferous tubules 
responsible for testosterone and sperm productions 
respectively. Damage to Leydig cells will result in 
decreased testosterone production, which will in turn 
decrease spermatogenesis. Thus, decrease in 
testosterone production/release and damage to the 
seminiferous tubules may account for the massive 
reduction in total sperm count observed in this study. 
Furthermore, there was an increase in 
primordial/premature cells with maturation arrest and 
histopathological damage (not shown) in this study. 
This may be due to inhibition of meiosis of primary 
spermatocytes into secondary spermatocyctes and 
haploid spermatids (the meiotic cell division phase of 
spermatogenesis) and an increase in mitotic activity, 
thus resulting in the production of many premature 
spermatozoa and reduced matured spermatozoa. The 
increase in structural abnormality (morphology) and 
cell debris which is a measure of the level of 
contamination/metabolic wastes, may also be 
explained by the above, as well as direct destructive 
actions on sperm cells. 
It has been shown that the proposed antiparasitic 
mechanism of action for the artesmisinins is through 
generation of free radicals- reactive oxygen species 
(Robert et al., 2000), with resulting in vitro and in 
vivo mitochondrial injury (Aitken et al., 2003).  
Furthermore, oxidative stress causes injury to 
genomic integrity in male germinal cells, resulting in 
infertility (Illingworth et al., 1996; Sharma and 
Agarwal, 1996). Thus, oxidative stress induced by 
these agents in seminal fluid, could directly or 
indirectly impair spermatogenesis and reproductive 
dysfunction observed in this study. 
 
Conclusion 
The present study has shown that artemisinin-
based combination treatments exert a 
potentiation/synergy of the toxicological effects of 
the component agents in the ACT on testicular 
function in the guinea-pig, which may be deleterious 
to the reproductive health of the animal. The results 
of this study also have a positive correlation with our 
earlier hormonal study, which shows decrease in the 
serum level of testosterone. The experiment is being 
carried out in humans to see if these results will be 
reproducible in humans. 
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